Combination: tumor resolution (% population):Sa1N fibrosarcoma: 70% MC38-colorectal adenocarcinoma: 80%Monotherapy: tumor resolutionPD-1 and LAG-3 monotherapy: 0–40%. This evidence concerns the gene LAG3 and colorectal adenocarcinoma.